.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
C Minor concentrated 79.94% of June 2026 sales in Capsules with a 28.09% YoY gain and a -6.07% MoM dip, while Oil held 20.06% share with a 166.70% YoY surge but a -44.78% MoM slide; the average price rose 3.41% YoY to $36.08. In Capsules, rank sat at 11 in Ontario, and brand-level sales were up 55.60% YoY despite a 24-month decline of -65.73%, indicating a portfolio leaning on Capsules for scale and Oil for volatility-driven increments.
The mix suggests Capsules are the defensible anchor given an 11th-place rank and nearly four-fifths share, while Oil’s triple-digit YoY alongside steep MoM contraction implies promotion- or batch-driven spikes that are not yet durable; with Capsules pricing at $34.42 vs. Oil at $44.66, margin strategy likely favors maintaining Capsules volume while selectively timing Oil activation. The pattern implies C Minor should position as a Capsules-led brand that uses episodic Oil pushes to capture incremental share without eroding the steadier Capsules base, prioritizing rank improvement in Capsules to convert YoY momentum into sustained placement.
Competitive Landscape
C Minor sits at rank #11 in ON Capsules for June 2026, improving 2 positions year over year from #13, yet unchanged versus March 2026 where it also held #13, indicating a modest upward shift but limited recent momentum; the brand’s peak of #9 in September 2024 underscores a 2-rank slippage from its historical best. In contrast, Glacial Gold climbed from #4 to #2 while expanding sales by 45.7%, and Redecan fell from #2 to #3 alongside a 41.2% sales contraction, suggesting room for C Minor to gain share if it can convert stability into upward movement. The pattern implies C Minor’s rank trajectory is stabilizing just outside the top 10, and breaking back into the top 10 will likely require outperforming mid-tier rivals whose ranks are moving more decisively.
Notable Products
CBG:CBD 1:2 Max 2250 Ultra Formula Oil (30ml) posted the steepest movement in June 2026 with an -85% month-over-month drop and slid to rank 4, implying a sharp pullback for experimental ratios within Oils. CBD Isolate 100 Max 3000 Oil (30ml) fell -37% MoM at rank 2 while CBD 50 Max 3000 Oil Drops (60ml) declined -42% MoM at rank 3, and three of the top four SKUs are Oils, concentrating share in a category that contracted simultaneously. CBD Fast Acting 50 Max Softgels 30-Pack (1500mg CBD) held rank 1 with a -6% MoM dip and approximately $26,079 in sales, outpacing the Oil SKUs by rank despite their heavier declines. The pattern implies C Minor’s commercial direction is tilting toward dependable Capsules leadership while the Oil portfolio needs repositioning, as category concentration without growth is eroding momentum.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
